Qihuang Zhuyu Formula Attenuates Atherosclerosis via Targeting PPARγ to Regulate Cholesterol Efflux and Endothelial Cell Inflammation

At present, due to the limitations of drug therapy targets for atherosclerosis, some patients fail to achieve satisfactory efficacy. Cholesterol efflux dysfunction and endothelial cell inflammation are considered to be important factors in the development of atherosclerosis. Peroxisome proliferator-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mengxi, Xiang, Qian, Sun, Weixin, Zhang, Haowen, Shi, Ruijie, Guo, Jun, Tong, Huaqin, Fan, Manlu, Ding, Yuhan, Shi, Haibo, Yu, Peng, Shen, Le, Wang, Qiong, Chen, Xiaohu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744610/
https://www.ncbi.nlm.nih.gov/pubmed/36518993
http://dx.doi.org/10.1155/2022/2226168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744610/
https://www.ncbi.nlm.nih.gov/pubmed/36518993
http://dx.doi.org/10.1155/2022/2226168

Ejemplares similares